MGD015 is a bispecific molecule that incorporates MacroGenics’ Dual-Affinity Re-Targeting (DART) platform. It redirects T cells, through their CD3 component, to remove cells that overexpress an undisclosed antigen
The variant, a twelve-letter deletion in the ASGR1 gene on chromosome 17, was discovered by analyzing the entire genome and clinical information from across the population of Iceland.
The approval is based on overall response rate in cHL patients who have relapsed or progressed after autologous hematopoietic stem cell transplantation (auto-HSCT) and post-transplantation brentuximab vedotin. Opdivo
Benralizumab demonstrated significant reductions in the annual asthma exacerbation rate compared to placebo. The trials, Sirocco and Calima, assessed the safety and efficacy of two dose regimens of
Last month, lawmakers failed to approve the US Government’s request for $1.9bn in emergency funding made in February. AHF said Congress is not concerned on the mosquito-borne and
The randomized, double-blind, standard of care-controlled trial, dubbed BLAST-AHF, assessed three doses of TRV027 plus standard heart failure therapy compared to placebo plus standard therapy in 618 patients
Pfizer will pay $99.25 in cash for each Anacor share. The transaction is scheduled to be completed in the third quarter of this year. Anacor is engaged in
The company enforced a distribution restriction for particular products that have been part of, or considered by various states for their lethal injection protocols. The products include pancuronium
US states and territories can now apply to the Centers for Disease Control and Prevention (CDC) for funds to fight Zika locally. The CDC said $25m in preparedness
Mylan will pay $950m in cash up front and up to $50m in future payments. The deal adds about 25 branded and generic products, a 25-product pipeline and
Advertise With UsAdvertise on our extensive network of industry websites and newsletters.
Get the PBR newsletterSign up to our free email to get all the latest PBR
news.